Subcutaneous versus Transvenous Implantable Defibrillators: a Systematic Review and Meta-Analysis

In patients with complex anatomy, high infection risk and venous access issues, subcutaneous implantable cardioverter-defibrillator (S-ICD) is presumed to be an appealing alternative to transvenous implantable cardioverter-defibrillator (T-ICD). T-ICD is known to cause perioperative and long-term complications. S-ICD does not offer anti-tachycardia pacing (ATP), back up pacing and chronic resynchronization therapy (CRT) but does have expanding indications. However, owing to0 ongoing uncertainty in efficacy and ambiguity in utility of S-ICD in low-risk patients, we performed this updated meta-analysis to study device related complications of both the systems.

Source: The American Journal of Cardiology - February 21, 2024 Category: Cardiology Authors: Maryam Saleem, Verda Arshad, Pooneh Nabavizadeh, Srinivas Rajsheker, Alexandru Costea Tags: Editorial Source Type: research